Stocks of Baxter International Inc (NYSE:BAX) traded higher last session on Wall Street, down -1.34% to $30.21.
BAX stock price is now -4.68% away from the 50-day moving average and -14.86% away from the 200-day moving average. The market capitalization of the company currently stands at $15.42B.
With the price target reduced from $39 to $30, Morgan Stanley Downgraded its rating from Equal-Weight to Underweight for Baxter International Inc (NYSE: BAX). On May 30, 2024, Goldman recently initiated its ‘Neutral’ rating on the stock quoting a target price of $36, while ‘TD Cowen’ rates the stock as ‘Hold’
In other news, Stevens Brian, Officer bought 976 shares of the company’s stock on Sep 16 ’24. The stock was bought for $39,046 at an average price of $40.01. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 13 ’24, Officer Stevens Brian bought 16,063 shares of the business’s stock. A total of $639,465 was incurred on buying the stock at an average price of $39.81. A total of 0.78% of the company’s stock is owned by insiders.
During the past 12 months, Baxter International Inc has had a low of $28.33 and a high of $44.01. As of last week, the company has a debt-to-equity ratio of 1.68, a current ratio of 1.43, and a quick ratio of 1.09. The fifty day moving average price for BAX is $31.8036 and a two-hundred day moving average price translates $35.5434 for the stock.
The latest earnings results from Baxter International Inc (NYSE: BAX) was released for 2024-09-30. The net profit margin was 0.83% and return on equity was -1.85% for BAX. The company reported revenue of $2.7 billion for the quarter, compared to $2.6 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.85 percent.
